These results suggest that DNA methylation and restoration of IGF-1 signaling mediate at least part of the cardioprotection by B12 in diabetic cardiomyopathy, independently of the direct superoxide scavenging effect of B12. Here, IGF1 is linked to diabetic cardiomyopathy.